Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors

International Journal of Oncology

Volumn 28, Issue 5, 2006, Pages 1217-1223

  Tsuchiya, Norihiko ^a   Mishina, Mutsuki ^b   Narita, Shintaro ^a   Kumazawa, Teruaki ^a   Inoue, Takamitsu ^a   Horikawa, Yohei ^a   Kakinuma, Hideaki ^a   Yuasa, Takeshi ^a   Matsuura, Shinobu ^a   Satoh, Shigeru ^a   Ogawa, Osamu ^c   Habuchi, Tomonori ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Allelic imbalance; Testicular germ cell tumor; XRCC1 polymorphism

Indexed keywords

DNA BINDING PROTEIN; PRIMER DNA; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ARTICLE; CANCER STAGING; CHROMOSOME ABERRATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; NEOPLASM; PATHOLOGY; POLYMERASE CHAIN REACTION; REFERENCE VALUE; TESTIS TUMOR;

CHROMOSOME ABERRATIONS; DNA PRIMERS; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE VALUES; TESTICULAR NEOPLASMS;

EID: 33646836123     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.5.1217     Document Type: Article

References (49)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
2. McKiernan JM, Goluboff ET, Liberson GL, Golden R and Fisch H: Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162: 361-363, 1999.
3. Nichols CR: Testicular cancer. Curr Probl Cancer 22: 187-274, 1998.
4. Ekbom A, Richiardi L, Akre O, Montgomery SM and Sparen P: Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst 95: 1238-1240, 2003.
5. Garner MJ, Turner MC, Ghadirian P and Krewski D: Epidemiology of testicular cancer: An overview. Int J Cancer 116: 331-339, 2005.
6. Richiardi L, Akre O, Montgomery SM, Lambe M, Kvist U and Ekbom A: Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J Natl Cancer Inst 96: 145-147, 2004.
7. Swerdlow AJ, Huttly SR and Smith PG: Prenatal and familial associations of testicular cancer. Br J Cancer 55: 571-577, 1987.
8. Henderson BE, Benton B, Jing J, Yu MC and Pike MC: Risk factors for cancer of the testis in young men. Int J Cancer 23: 598-602, 1979.
9. Akre O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A and Ekbom A: Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer 82: 1-5, 1999.
10. Schwartz GG: Hypothesis: does ochratoxin A cause testicular cancer? Cancer Causes Control 13: 91-100, 2002.
11. Forman D, Oliver RT, Brett AR, Marsh SG, Moses JH, Bodmer JG, Chilvers CE and Pike MC: Familial testicular cancer: A report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 65: 255-262, 1992.
12. Rajpert-De Meyts E, Leffers H, Daugaard G, Andersen CB, Petersen PM, Hinrichsen J, Pedersen LG and Skakkebaek NE: Analysis of the polymorphic CAG repeat length in the androgen receptor gene in patients with testicular germ cell cancer. Int J Cancer 102: 201-204, 2002.
13. Aschim EL, Giwercman A, Stahl O, Eberhard J, Cwikiel M, Nordenskjold A, Haugen TB, Grotmol T and Giwercman YL: The RsaI polymorphism in the ER{beta} gene is associated with male infertility. J Clin Endocrinol Metab 90: 5343-5348, 2005.
14. Laska MJ, Nexo BA, Vistisen K, Poulsen HE, Loft S and Vogel U: Polymorphisms in RAI and in genes of nucleotide and base excision repair are not associated with risk of testicular cancer. Cancer Lett 225: 245-251, 2005.
15. Harries LW, Stubbins MJ, Forman D, Howard GC and Wolf CR: Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-644, 1997.
16. Giwercman A, Lundin KB, Eberhard J, Stahl O, Cwikiel M, Cavallin-Stahl E and Giwercman YL: Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage. Eur J Cancer 40: 2152-2158, 2004.
17. Ottesen AM, Kirchhoff M, De-Meyts ER, Maahr J, Gerdes T, Rose H, Lundsteen C, Petersen PM, Philip J and Skakkebaek NE: Detection of chromosomal aberrations in seminomatous germ cell tumours using comparative genomic hybridization. Genes Chromosomes Cancer 20: 412-418, 1997.
18. Rothe M, Albers P and Wernert N: Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours. J Pathol 188: 389-394, 1999.
19. Bouras M, Tabone E, Bertholon J, Sommer P, Bouvier R, Droz JP and Benahmed M: A novel SMAD4 gene mutation in seminoma germ cell tumors. Cancer Res 60: 922-928, 2000.
20. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A and Heinrich MC: KIT mutations are common in testicular seminomas. Am J Pathol 164: 305-313, 2004.
21. Edwards AA, Virsik-Peuckert P and Bryant P: Mechanisms of radiation-induced chromosome aberrations. Mutat Res 366: 117-128, 1996.
22. Lunn RM, Langlois RG, Hsieh LL, Thompson CL and Bell DA: XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561, 1999.
23. Hsieh LL, Chien HT, Chen IH, Liao CT, Wang HM, Jung SM, Wang PF, Chang JT, Chen MC and Cheng AJ: The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 12: 439-443, 2003.
24. Lei YC, Hwang SJ, Chang CC, Kuo HW, Luo JC, Chang MJ and Cheng TJ: Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res 519: 93-101, 2002.
25. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S and Wu X: From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2: 901-908, 2003.
26. Olshan AF, Watson MA, Weissler MC and Bell DA: XRCC1 polymorphisms and head and neck cancer. Cancer Lett 178: 181-186, 2002.
27. David-Beabes GL and London SJ: Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 34: 333-339, 2001.
28. Kim SU, Park SK, Yoo KY, Yoon KS, Choi JY, Seo JS, Park WY, Kim JH, Noh DY, Ahn SH, Choe KJ, Strickland PT, Hirvonen A and Kang D: XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 12: 335-338, 2002.
29. Taylor RM, Thistlethwaite A and Caldecott KW: Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol 22: 2556-2563, 2002.
30. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Strom SS, Spitz MR and Wei Q: Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129, 1999.
31. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L and Christiani DC: Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 12: 359-365, 2003.
32. Shu XO, Cai Q, Gao YT, Wen W, Jin F and Zheng W: A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12: 1462-1467, 2003.
33. Mostofi FK and Sobin LH: Histological typing of testis tumors. International Histological Classification of Tumors. Vol. 16. WHO, Geneva, 1997.
34. UICC: TNM Classification of Malignant tumors. 3rd edition. Springer-Verlag, Berlin, 1989.
35. Boyle P and Zaridze DG: Risk factors for prostate and testicular cancer. Eur J Cancer 29A: 1048-1055, 1993.
36. Skakkebaek NE, Berthelsen JG and Muller J: Carcinoma-in situ of the undescended testis. Urol Clin North Am 9: 377-385, 1982.
37. Swerdlow AJ, De Stavola B, Maconochie N and Siskind V: A population-based study of cancer risk in twins: relationships to birth order and sexes of the twin pair. Int J Cancer 67: 472-478, 1996.
38. Moller H: Work in agriculture, childhood residence, nitrate exposure, and testicular cancer risk: a case-control study in Denmark. Cancer Epidemiol Biomarkers Prev 6: 141-144, 1997.
39. Habash RW, Brodsky LM, Leiss W, Krewski D and Repacholi M: Health risks of electromagnetic fields. Part I: evaluation and assessment of electric and magnetic fields. Crit Rev Biomed Eng 31: 141-195, 2003.
40. Verreault R, Weiss NS, Hollenbach KA, Strader CH and Daling JR: Use of electric blankets and risk of testicular cancer. Am J Epidemiol 131: 759-762, 1990.
41. Pettersson A, Kaijser M, Richiardi L, Askling J, Ekbom A and Akre O: Women smoking and testicular cancer: one epidemic causing another? Int J Cancer 109: 941-944, 2004.
42. Coupland CA, Forman D, Chilvers CE, Davey G, Pike MC and Oliver RT: Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes Control 15: 277-283, 2004.
43. Haughey BP, Graham S, Brasure J, Zielezny M, Sufrin G and Burnett WS: The epidemiology of testicular cancer in upstate New York. Am J Epidemiol 130: 25-36, 1989.
44. Gharbi A, Trillon O, Betbeder AM, Counord J, Gauret MF, Pfohl-Leszkowicz A, Dirheimer G and Creppy EE: Some effects of ochratoxin A, a mycotoxin contaminating feeds and food, on rat testis. Toxicology 83: 9-18, 1993.
45. Inoue T, Ito T, Narita S, Horikawa Y, Tsuchiya N, Kakinuma H, Mishina M, Nakamura E, Kato T, Ogawa O and Habuchi T: Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients. Cancer Lett (In press).
46. Nelson HH, Kelsey KT, Mott LA and Karagas MR: The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 62: 152-155, 2002.
47. Hu Z, Ma H, Chen F, Wei Q and Shen H: XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14: 1810-1818, 2005.
48. Peng HQ, Bailey D, Bronson D, Goss PE and Hogg D: Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 55: 2871-2875, 1995.
49. Takebayashi Y, Nakayama K, Kanzaki A, Miyashita H, Ogura O, Mori S, Mutoh M, Miyazaki K, Fukumoto M and Pommier Y: Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors. Cancer Lett 174: 115-125, 2001.